Update on drugs for hyperactivity in childhood
Relevant BNF section: 4.4
In 2001, we concluded that methylphenidate or dexamfetamine can be useful adjunctive therapy for children with severe hyperactivity in whom non-drug approaches alone have been inadequate.1 Since then,
atomoxetine (pronounced a-toe-moks-e-teen; Strattera – Lilly) and three modified-release formulations of methylphenidate have been launched for attention deficit hyperactivity disorder (ADHD). Here we reconsider drugs for ADHD in childhood, focusing on the newer products.
This article has been cited by other articles:
-
(2007). Clarification: Update on drugs for hyperactivity in childhood. DTB
45: 88-88
[Full Text]
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
